Bath & Body Works Non-GAAP EPS of $0.62 beats by $0.38, revenue of $1.51B beats by $10M, raises FY guidance
Bath & Body Works Non‑GAAP EPS of $0.62 exceeded $0.38, revenue of $1.51B exceeded $10M, and the company raised its FY guidance, providing a positive earnings catalyst.
The current price of 17.58 is close to the 20‑day low support level of 17.43, and with news that EPS and revenue significantly exceeded expectations and FY guidance was raised, we anticipate a rebound near the support and therefore buy.
I will buy at the current price of 17.58, take profit when the price reaches the resistance level of 21.34, and cut loss when the price falls to the support level of 17.43.
RSI(14)=32.2 (oversold), moving average misalignment (weak trend), volume 2.23 times the 20‑day average (volume surge), recent 7‑day change -8.5% (downtrend)
On 2026‑08‑18, it declined -1.8%; on 2026‑08‑07, -1.6%; on 2026‑07‑16, -1.2%; and in the past, similar‑sized declines were observed after earnings announcements, which is similar to the current situation.
Actual return of 10.1% significantly exceeded the forecasted return of 3.5%, and the price rose to the target of 21.34, satisfying the take-profit condition. The stop-loss level was never touched, indicating that risk management functioned adequately. News and technical indicators sufficiently reflected upside potential, but the magnitude of the rise was underestimated.
In the next trade, we will more actively utilize oversold signals when the RSI is 30 or below, and combine a surge in trading volume with proximity to support to adjust entry timing. When setting the target price, we will consider a level slightly above the current resistance, and set the stop‑loss just below the support to minimize risk.